Sign in

CIK 0001604821

  • Large accelerated filer

Natera, Inc.

Sign in to watch
Ticker
NTRA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
010894487
Phone
+1 650-249-9090
Business address
13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
Former names
Natera, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$104,832,418
in 28 filings, $104.8M under 10b5-1 plans

Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-12-18 Sheena Jonathan Director Sale 10b5-1 −152 $166.01 $25K 47,630
2024-12-18 Sheena Jonathan Director Sale 10b5-1 −852 $167.07 $142K 46,778
2024-12-18 Sheena Jonathan Director Sale 10b5-1 −496 $168.02 $83K 46,282
2024-12-13 Rabinowitz Matthew EXECUTIVE CHAIRMAN Sale 10b5-1 −28,681 $164.61 $4.7M 2,520,499
2024-12-13 Rabinowitz Matthew EXECUTIVE CHAIRMAN Sale 10b5-1 −75,323 $165.45 $12.5M 2,445,176
2024-12-13 Rabinowitz Matthew EXECUTIVE CHAIRMAN Sale 10b5-1 −45,769 $166.45 $7.6M 2,399,407
2024-12-13 Rabinowitz Matthew EXECUTIVE CHAIRMAN Sale 10b5-1 −4,927 $167.39 $825K 2,394,480
2024-12-13 Rabinowitz Matthew EXECUTIVE CHAIRMAN Sale 10b5-1 −5,300 $168.35 $892K 2,389,180
2024-12-10 Chapman Rowan E Director Sale −1,767 $170.24 $301K 6,202
2024-12-09 Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Grant or award 10b5-1 +5,752 $7.45 $43K 116,447
2024-12-09 Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Grant or award 10b5-1 +3,323 $12.85 $43K 119,770
2024-12-09 Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Sale 10b5-1 −4,858 $166.59 $809K 114,912
2024-12-09 Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Exercise or conversion · Stock Option (right to buy) 10b5-1 −5,752 0
2024-12-09 Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Exercise or conversion · Stock Option (right to buy) 10b5-1 −3,323 0
2024-12-05 Rabinowitz Matthew EXECUTIVE CHAIRMAN Exercise or conversion +68,496 $5.40 $370K 2,549,180
2024-12-05 Rabinowitz Matthew EXECUTIVE CHAIRMAN Exercise or conversion · Stock Option (right to buy) −68,496 0
2024-12-02 BOTHA ROELOF Director Sale −8,783 $166.88 $1.5M 1,303,477
2024-12-02 BOTHA ROELOF Director Sale −10,447 $167.59 $1.8M 1,293,030
2024-12-02 BOTHA ROELOF Director Sale −16,853 $168.73 $2.8M 1,276,177
2024-12-02 BOTHA ROELOF Director Sale −40,171 $169.78 $6.8M 1,236,006

Page 61 of 85 · 1,682 trades